Search Results - "MacLennan, P.A"

  • Showing 1 - 8 results of 8
Refine Results
  1. 1

    Dosing Eculizumab for Antibody-Mediated Rejection in Kidney Transplantation: A Case Report by Smith, B, Kumar, V, Mompoint-Williams, D, Reed, R.D, MacLennan, P.A, Stegner, K, Locke, J.E

    Published in Transplantation proceedings (01-11-2016)
    “…Abstract Severe antibody-mediated rejection (AMR) of a blood type–incompatible (ABOi) living donor kidney transplantation (LDKT) can lead to graft failure, and…”
    Get full text
    Journal Article
  2. 2

    Impact of Protease Inhibitor–Based Anti‐Retroviral Therapy on Outcomes for HIV+ Kidney Transplant Recipients by Sawinski, D., Shelton, B. A., Mehta, S., Reed, R. D., MacLennan, P. A., Gustafson, S., Segev, D. L., Locke, J. E.

    Published in American journal of transplantation (01-12-2017)
    “…Excellent outcomes have been demonstrated among select HIV‐positive kidney transplant (KT) recipients with well‐controlled infection, but to date, no national…”
    Get full text
    Journal Article
  3. 3

    The Impact of Proposed Changes in Liver Allocation Policy on Cold Ischemia Times and Organ Transportation Costs by DuBay, D. A., MacLennan, P. A., Reed, R. D., Fouad, M., Martin, M., Meeks, C. B., Taylor, G., Kilgore, M. L., Tankersley, M., Gray, S. H., White, J. A., Eckhoff, D. E., Locke, J. E.

    Published in American journal of transplantation (01-02-2015)
    “…Changes to the liver allocation system have been proposed to decrease regional variation in access to liver transplant. It is unclear what impact these changes…”
    Get full text
    Journal Article
  4. 4

    Identification of Optimal Donor–Recipient Combinations Among Human Immunodeficiency Virus (HIV)–Positive Kidney Transplant Recipients by Locke, J. E., Shelton, B. A., Reed, R. D., MacLennan, P. A., Mehta, S., Sawinski, D., Segev, D. L.

    Published in American journal of transplantation (01-08-2016)
    “…For some patient subgroups, human immunodeficiency virus (HIV) infection has been associated with worse outcomes after kidney transplantation (KT); potentially…”
    Get full text
    Journal Article
  5. 5

    Increased Mortality and Graft Loss With Kidney Retransplantation Among Human Immunodeficiency Virus (HIV)–Infected Recipients by Shelton, B. A., Mehta, S., Sawinski, D., Reed, R. D., MacLennan, P. A., Gustafson, S., Segev, D. L., Locke, J. E.

    Published in American journal of transplantation (01-01-2017)
    “…Excellent outcomes have been demonstrated in primary human immunodeficiency virus (HIV)–positive (HIV+) kidney transplant recipients, but a subset will lose…”
    Get full text
    Journal Article
  6. 6
  7. 7

    Skeletal muscle glutamine transport, intramuscular glutamine concentration, and muscle-protein turnover by Rennie, M J, MacLennan, P A, Hundal, H S, Weryk, B, Smith, K, Taylor, P M, Egan, C, Watt, P W

    Published in Metabolism, clinical and experimental (01-08-1989)
    “…This article reviews work we have carried out to investigate (1) the transport mechanisms responsible for the high distribution ratio of free glutamine…”
    Get more information
    Journal Article
  8. 8